These findings indicate that both PP2A and PP1 could be putative targets of therapeutic intervention in AD, which has also been proposed by others (Braithwaite et al., 2012; Torrent & Ferrer, 2012). The gene discussed is PTPA; the disease is Alzheimer disease.